MARKET

STIM

STIM

Neuronetics
NASDAQ
3.300
+0.270
+8.91%
After Hours: 3.270 -0.03 -0.91% 16:35 08/14 EDT
OPEN
3.060
PREV CLOSE
3.030
HIGH
3.305
LOW
2.950
VOLUME
1.96M
TURNOVER
--
52 WEEK HIGH
4.290
52 WEEK LOW
0.8000
MARKET CAP
251.45M
P/E (TTM)
-6.0384
1D
5D
1M
3M
1Y
5Y
1D
Neuronetics Is Maintained at Buy by BTIG
Dow Jones · 3d ago
Neuronetics Price Target Raised to $6.00/Share From $5.00 by BTIG
Dow Jones · 3d ago
BTIG Maintains Buy on Neuronetics, Raises Price Target to $6
Benzinga · 3d ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 3d ago
Neuronetics Q2 Earnings Call Highlights
NASDAQ · 3d ago
Neuronetics (STIM) Reports Q2 Loss, Beats Revenue Estimates
NASDAQ · 3d ago
Neuronetics' Q2 Revenue Rises 9%; Adjusted EBITDA Turns Positive, Narrows 2026 Outlook
NASDAQ · 3d ago
Neuronetics narrows losses and boosts margins in Q2
TipRanks · 3d ago
More
About STIM
Neuronetics, Inc. a vertically integrated, commercial stage, medical technology and healthcare company. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The Company provides more than 7.1 million treatments to over 1,95,000 patients.

Webull offers Neuronetics Inc stock information, including NASDAQ: STIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STIM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STIM stock methods without spending real money on the virtual paper trading platform.